Wednesday, 17 February 2021BioPharmaChem Ireland, the Ibec group that represents the BioPharma and Chemical sector in Ireland, has welcomed the latest export figures from the Central Statistics Office that show that the domestic biopharmaceutical and chemical sector had an export value of €106 billion in 2020 - the first time a sector has exceeded the €100 billion mark in a single year. This represents 67% of the total goods exported from this country.
Commenting on the figures, BioPharmaChem Ireland Director, Matt Moran said: “The Irish BioPharma Sector has stayed fully operational right the way through the Covid-19 Pandemic. Companies have invested significant time and resources to ensure that their workforce remains safe and can ensure that the world stays supplied with essential medicines and other valuable chemical products.
“The CSO export figures for 2020 provide ample evidence of the continued strength of the industry. In 2020 the biopharmaceutical sector alone exported products to a total value of €93 billion, up 17% on 2019.
“The 2020 CSO Export numbers emphasise the importance of the biopharma and chemical sectors this country, in no small part they have helped to lessen the damaging impact of Covid-19 on our economy. The large increase in exports has been driven by the large amount of capital investment – over €10 billion – that this sector has committed to Ireland.
“We look forward to further growth in the sector. It is important that Ireland now invests in Advanced Therapeutics – therefore it was great to see Takeda announcing a €36 million investment in its cellular production facility at Grangecastle, Dublin where they will create a further 100 jobs. The future remains bright for this important sector.”